Back

SGLT2 inhibition: the potential to change the heart failure landscape? Q&A.

1 May 2017 (13:35 - 13:40)
Organised by:
Congress Presentation Part of: Heart failure: what is the potential of SGLT2 inhibition? Chronic heart failure Open Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Doctor S. Williams (Manchester, GB) Doctor J. Day (Luton, GB)
Slides Video
Presentation thumbnail
The ongoing problem of heart failure.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
The ongoing problem of heart failure - Q&A.
Doctor S. Williams (Manchester, GB) Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
SGLT2 inhibition: the potential to change the heart failure landscape?
Doctor M. Kosiborod (Kansas City, US)
Slides Video
Presentation thumbnail
Summary and close.
Doctor S. Williams (Manchester, GB)
Slides

Access the full session

Session thumbnail
Heart failure: what is the potential of SGLT2 inhibition?

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 13:35 CET
You may be interested in
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025
thumbnail
Congress Presentation
Eligibility and prescribing rates of SGLT2 inhibitors for patients with heart failure from a large tertiary centre
29 June 2021
thumbnail
Congress Presentation
Summary.
29 August 2022
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources